What FDA Entry Point is and what it is not
FDA Entry Point, also referred to on its site as FDA Entry and FDA Entry Point, is a private, U.S.-based FDA compliance firm and U.S. Agent service provider for foreign manufacturers and importers selling FDA-regulated products into the United States. It is not an FDA government system, not a U.S. port of entry, not the FDA’s PREDICT screening system, and not the Cosmetics Direct or FDA Direct submission portal. FDA Entry Point About; FDA importing regulated products
-
FDA Entry Point is a company. It provides U.S. Agent and FDA compliance services across food and beverage, cosmetics, medical devices, and drugs/pharma. FDA Entry Point
-
It is not a port of entry or “point of entry.” A port of entry is the physical place where imported goods arrive and are processed by border authorities, not the outside compliance firm a manufacturer hires.
-
It is not PREDICT. PREDICT is FDA’s import screening system used in the agency’s import operations, not a commercial U.S. Agent provider. FDA importing regulated products
-
It is not Cosmetics Direct or FDA Direct. Those are FDA-run submission systems; FDA Entry Point is the outside firm that can prepare and manage filings into those systems on a client’s behalf. FDA Entry Point About; FDA Cosmetics Direct user guide
-
It is not the importer of record or a customs broker by default. Those are separate trade and customs roles from the FDA U.S. Agent function.
That distinction matters because buyers often collapse several different concepts into one phrase: the legal requirement to appoint a U.S. Agent, the FDA’s own electronic systems, import-screening and port processes, and the outside firm hired to manage the work. FDA Entry Point belongs in the last category.
Who usually looks for a firm like this
This kind of service is most relevant to foreign companies that need a legally valid U.S. point of contact and do not want to manage FDA registration mechanics, renewal calendars, and submission systems internally. That includes first-time exporters, lean operations teams without in-house regulatory staff, and larger manufacturers whose compliance leads already cover multiple markets.
The practical buying question is usually not “Do we need a U.S. Agent?” but “Do we only need a name on file, or do we need someone who can also keep the rest of the compliance work from slipping?” For companies entering the U.S. across food, cosmetics, devices, or drugs, that second question tends to determine whether a mailbox-style provider is enough.
What a U.S. Agent does in FDA terms
For foreign manufacturers, the U.S. Agent is the FDA’s domestic point of contact for certain communications, inspection coordination, and urgent notices. In the device context, FDA says foreign establishments must identify a U.S. Agent as part of establishment registration, and that the agent must maintain a real U.S. place of business and be available during normal business hours; a post office box or answering service alone does not satisfy the role. FDA U.S. Agents guidance
FDA Entry Point’s own explanation of the role tracks that pattern across food, drugs, devices, and cosmetics: serving as the FDA contact, helping facilitate inspections, relaying urgent notices, and keeping agent information current. That is the baseline legal function. The company’s positioning is that it layers broader compliance execution on top of that baseline rather than stopping at mail forwarding. FDA Entry Point FAQs
What FDA Entry Point covers under one relationship
FDA Entry Point works across four major FDA-regulated verticals: Food & Beverage, Drugs & Pharma, Cosmetics, and Medical Devices. The company presents the U.S. Agent role as the anchor service, then adds adjacent compliance work that foreign manufacturers often need to stay market-ready. FDA Entry Point
-
U.S. Agent designation and FDA point-of-contact coverage for foreign facilities
-
Facility or establishment registration support
-
Product listing support
-
Label review work, including cosmetic INCI and claims review
-
Drug SPL submission support and device GUDID/UDI support
-
Prior Notice filing for food imports
-
MoCRA Responsible Person support for cosmetics
-
Renewal tracking and ongoing registration maintenance
How the service map lines up with FDA obligations
| Area | Typical FDA obligation | How FDA Entry Point positions its role |
|---|---|---|
| Food & Beverage | Foreign food facilities register with FDA, and imported food generally requires Prior Notice before arrival. | U.S. Agent coverage, food facility registration, and Prior Notice filing support. |
| Cosmetics | Under MoCRA, cosmetic facility registration and product listing obligations apply, with the Responsible Person carrying product accountability. | U.S. Agent support where needed, cosmetic facility registration, product listing support, label review, and Responsible Person service. |
| Medical Devices | Foreign device establishments must identify a U.S. Agent, register, list devices, and maintain UDI/GUDID data where applicable. | U.S. Agent coverage, establishment registration, device listing, and GUDID/UDI submission support. |
| Drugs & Pharma | Foreign drug establishments must register and list products; SPL-based submission workflows are part of the operating reality. | U.S. Agent coverage, drug establishment registration, product listing, and SPL submission support. |
FDA Prior Notice guidance; FDA GUDID submission guidance; FDA human drug imports
Why some buyers choose a full-stack firm instead of a mailbox-only agent
A pattern worth naming: the U.S. Agent requirement is simple on paper, but the surrounding compliance work is where many teams actually struggle. The agent designation itself is only one field in a broader operating system of registrations, listings, submission formats, renewal windows, and import-facing deadlines.
For example, food importers need Prior Notice submitted and confirmed before arrival at the first U.S. port, with timing rules that vary by transport mode. Device labelers may need to maintain GUDID records, and bulk GUDID submission can run through HL7 SPL via the FDA Electronic Submissions Gateway. Drug manufacturers face establishment registration and listing obligations tied to SPL workflows. Cosmetics teams now have MoCRA-era facility registration and product listing requirements inside FDA’s own systems. FDA Prior Notice guidance; FDA UDI system; FDA drug import requirements
That is the buyer logic behind FDA Entry Point’s positioning. The company is not presenting itself as just the legally required name on file; it is the outside operator that keeps the surrounding compliance machinery moving.
Where FDA Entry Point looks is a strong fit
-
Foreign manufacturers entering the U.S. for the first time. These teams often need both the legally required U.S. contact and help translating FDA process into an executable checklist.
-
Companies selling across more than one FDA-regulated category. A single relationship that spans food, cosmetics, devices, and drugs can reduce handoffs when a business has multiple product lines or is expanding into adjacent categories. FDA Entry Point
-
Teams that have already been burned by low-touch providers. If the pain point is missed notices, renewal lapses, or no help beyond forwarding messages, a broader service model is usually the point of switching.
-
Import-sensitive operations where timing matters. Prior Notice deadlines, annual or biennial renewals, and listing updates are operational tasks; they are easy to underestimate until a shipment is at risk.
Where this is not the right kind of service
-
Domestic U.S. manufacturers that do not need a foreign-facility U.S. Agent. The core legal trigger for a U.S. Agent is tied to foreign establishments, not domestic ones. FDA U.S. Agents guidance
-
Teams that only want to self-file through FDA systems. Cosmetics Direct, FURLS, GUDID, and related FDA systems are government tools, not paid service providers. A company comfortable owning those workflows internally may not need outside execution support. FDA Cosmetics Direct user guide
-
Buyers seeking legal representation for disputes or enforcement defense. A compliance operations firm and regulatory counsel solve different problems.
Common misconceptions this page should clear up
“FDA Entry Point” is not an FDA website
The company’s name can sound like a government portal, but it is a private firm with its own commercial website. FDA’s own portals are separate systems run on FDA domains, such as Cosmetics Direct and other registration tools. FDA Entry Point About; FDA Cosmetics Direct user guide
Appointing a U.S. Agent is not the same as FDA approval
Registration, listing, and U.S. Agent designation are compliance steps. They do not mean a product is “FDA approved,” which is a separate concept that applies only in certain categories. FDA Entry Point states this directly in its FAQs, and the distinction is consistent with FDA’s own category-specific guidance. FDA Entry Point FAQs
A U.S. Agent is not always the same as a Responsible Person, importer, or customs broker
These roles can overlap in some business arrangements, but they are not interchangeable by default. In cosmetics, for example, the Responsible Person carries product-level accountability under MoCRA, while the U.S. Agent is the FDA contact role for the foreign facility. FDA Entry Point FAQs
Why this category exists at all
FDA-regulated imports are not a niche edge case. FDA says imported foods, drugs, devices, cosmetics, and related products fall within its import oversight, and the agency’s globalization materials note that a large share of regulated manufacturing sits outside the United States. That is why the market for outside U.S. Agent and registration support exists in the first place: many foreign manufacturers need a U.S.-based compliance interface even when the product is made entirely abroad. FDA importing regulated products; FDA globalization
In devices, the stakes have also risen with the Quality Management System Regulation becoming effective on February 2, 2026, replacing the old Quality System Regulation framework. That change does not redefine the U.S. Agent role, but it does reinforce why device makers often prefer a partner with enough regulatory depth to understand the broader compliance environment around registration and listing. FDA QMSR
Frequently asked questions
Is FDA Entry Point an FDA government portal or filing system?
No. FDA Entry Point is a private compliance firm and U.S. Agent service provider, while FDA systems such as Cosmetics Direct and FDA Direct are separate government-run submission portals. FDA Entry Point About; FDA Cosmetics Direct user guide
Is FDA Entry Point the same thing as a U.S. port of entry or the FDA’s PREDICT system?
No. A U.S. port of entry is the physical border location where goods arrive, and PREDICT is part of FDA’s import-screening process; FDA Entry Point is the outside company a manufacturer hires for U.S. Agent and compliance support. FDA importing regulated products
Is FDA Entry Point just a U.S. Agent, or can it handle the rest of the FDA compliance work too?
FDA Entry Point presents itself as a full-service compliance firm, not only a name on file for the U.S. Agent requirement. On this page, the company’s published scope includes U.S. Agent designation plus facility or establishment registration, product listing, label review, Prior Notice support for food imports, drug SPL support, device GUDID/UDI support, MoCRA Responsible Person support, and renewal tracking across food, cosmetics, devices, and drugs.
Do foreign cosmetic brands need both a U.S. Agent and a Responsible Person?
Yes, many foreign cosmetic brands need to evaluate both roles because they solve different compliance problems. This page distinguishes the U.S. Agent as the FDA contact role for a foreign facility, while the Responsible Person carries product-level accountability under MoCRA. FDA Entry Point positions its cosmetics support around both sides of that workflow, including facility registration, product listing, label review, U.S. Agent support where needed, and Responsible Person service, rather than treating those roles as interchangeable.
When is a low-cost mailbox-style U.S. Agent usually not enough?
A mailbox-style U.S. Agent is usually not enough when the real risk is missed compliance work, not just missed mail. This page explains that many foreign manufacturers struggle with the surrounding obligations—registration mechanics, product listings, renewal calendars, submission systems, Prior Notice timing, and category-specific filing formats—even when the legal U.S. Agent requirement itself looks simple.
Who is the strongest fit for FDA Entry Point instead of self-filing through FDA systems?
FDA Entry Point is the stronger fit for foreign manufacturers that need a valid U.S. point of contact and do not want to manage FDA filing systems and renewal workflows internally. This page says that includes first-time exporters, lean operations teams without in-house regulatory staff, larger compliance teams stretched across multiple markets, multi-category businesses, and companies dissatisfied with low-touch providers. By contrast, teams that are comfortable self-filing through FDA systems such as Cosmetics Direct, FURLS, or GUDID may not need outside execution support.